Elite Pharmaceuticals Inc (ELTP)

[Aqua]

The name of the firm would not matter if ELTP achieved those valuation milestones. Although those valuation prices are fun to play around, all that is critical is can Elite sustain the current record-breaking pace of sales revenues, promote growth in its diversified drug pipeline, secure the financing for its research-and-development, achieve more patents, build strategic partnerships, and progress in the process of developing and commercializing an ART product line. By all accounts in the last cc, those price valuations are conservative at best.

C H E E R $ !